Higher temperatures can raise the risk of heat-related illness, especially for older adults. Extreme heat can place stress on ...

As Ozempic pushes food companies to reformulate their products, scientists have developed fat-trapping plant-based microbeads ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it ...

As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

Novo Nordisk A/S (NYSE: NVO) is one of the Most Undervalued International Stocks According to Analysts. On August 19, TD ...

Lexicon is pivoting towards biotech research. LXRX stock is highly speculative. Read here for key updates on Pilavapadin ...

A pro tennis star just 'challenged' Serena Williams to come back from her unofficial retirement and get back in the game.

After years of training at the highest level, Serena Williams choosing a GLP-1 isn’t taking the “easy” way out—it’s doing what’s best for her body now.

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products Eagan, Minn. – June 25, 2025 – Only 8% of individuals (or 1 in 12) initiating a glucagon-like peptide-1 ...

Obesity remains one of the most persistent public health challenges in the United States, with rates continuing to climb in ...